7Baggers

Protara Therapeutics Quarterly Income Statements Chart

Quarterly
 | 
Annual
 
 Revenue  
 Gross Profit  
 Operating Profit  
 Net Income  
20140930 -7.46-5.97-4.48-3-1.51-0.031.462.95Milllion

Protara Therapeutics Quarterly Income Statements Table

Quarterly
 | 
Annual
 
Unit: USD2014-09-30 
  revenue2,948,000 
  cost of revenue
  gross profit2,948,000 
  operating expenses 
  research and development1,773,000 
  sales, general and administrative 
  total operating expenses2,814,000 
  operating income134,000 
  net income-7,458,000 

We provide you with 20 years income statements for Protara Therapeutics stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Protara Therapeutics stock. Explore the full financial landscape of Protara Therapeutics stock with our expertly curated income statements.

The information provided in this report about Protara Therapeutics stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.